反应条件
1: N,N-Dimethylaminoacetaldehyde diethyl acetal With hydrogenchloride in water T=20 - 30°C; Inert atmosphere; 2: Diethyl {[4-(3-Chloro-4-Fluoro-Phenylamino)-7-((S)-Tetrahydrofuran-3-Yloxy)-Quinazolin-6-Ylcarbamoyl]-Methyl}-Phosphonate With lithium chloride; potassium hydroxide in tetrahydrofuran T=-15 - 20°C; 2.5 h; Inert atmosphere; Product distribution / selectivity;
参考文献
RATIOPHARM GMBH; TEVA PHARMACEUTICALS USA, INC.; GIDWANI, Ramesh, Matioram; HIREMATH, Channaveerayya; YADAV, Manoj, Dalsingar; ALBRECHT, Wolfgang; FISCHER, Dirk
Patent: WO2012/121764 A1, 2012 ;
Location in patent: Page/Page column 49-50 ;